Neuraxis, INC price to book ratio NRXS

Market value divided by the book value of the company's net assets, since 2025.

Today, Oct 23, 2026: 13.8×
Peer median: 1.9×

Neuraxis, INC's price to book ratio is 13.8× as of Oct 23, 2026.

The median for 10 healthcare stocks of a similar size is 1.9×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	13.8×	10.7×	32.0×
2025	18.3×	5.6×	84.6×

Against its peers

Companies in Healthcare nearest Neuraxis, INC's size, closest first, today.

Company	Price to book ratio
NRXSNeuraxis, INC	13.8×
ICCCImmucell	3.0×
KEQUKewaunee Scientific	1.3×
LFVNLifevantage	2.2×
SPROSpero Therapeutics	1.5×
APTAlpha Pro Tech	0.9×
ATNMActinium Pharmaceuticals	1.6×
PDEXPro DEX	4.2×
PLXProtalix BioTherapeutics	2.9×
NATRNatures Sunshine Products	1.3×
ELMDElectromed	4.1×
Peer median	1.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Neuraxis, INC

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.